JP2010503624A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010503624A5 JP2010503624A5 JP2009527719A JP2009527719A JP2010503624A5 JP 2010503624 A5 JP2010503624 A5 JP 2010503624A5 JP 2009527719 A JP2009527719 A JP 2009527719A JP 2009527719 A JP2009527719 A JP 2009527719A JP 2010503624 A5 JP2010503624 A5 JP 2010503624A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- unsubstituted
- het
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006042927.3 | 2006-09-13 | ||
| DE102006042927 | 2006-09-13 | ||
| PCT/EP2007/007612 WO2008031508A1 (de) | 2006-09-13 | 2007-08-31 | Tartratderivate als inhibitoren des koagulationsfaktors ixa |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010503624A JP2010503624A (ja) | 2010-02-04 |
| JP2010503624A5 true JP2010503624A5 (https=) | 2010-09-30 |
| JP5249225B2 JP5249225B2 (ja) | 2013-07-31 |
Family
ID=38720737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009527719A Expired - Fee Related JP5249225B2 (ja) | 2006-09-13 | 2007-08-31 | 凝固第ＩＸａ因子インヒビターとしての使用のための酒石酸誘導体 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8263621B2 (https=) |
| EP (1) | EP2069288B1 (https=) |
| JP (1) | JP5249225B2 (https=) |
| KR (1) | KR20090053813A (https=) |
| CN (1) | CN101516833B (https=) |
| AR (1) | AR062744A1 (https=) |
| AU (1) | AU2007297012B2 (https=) |
| BR (1) | BRPI0716778A2 (https=) |
| CA (1) | CA2663543A1 (https=) |
| CL (1) | CL2007002651A1 (https=) |
| CO (1) | CO6220943A2 (https=) |
| IL (1) | IL197505A0 (https=) |
| MA (1) | MA30706B1 (https=) |
| MX (1) | MX2009001990A (https=) |
| MY (1) | MY148254A (https=) |
| NO (1) | NO20091106L (https=) |
| NZ (1) | NZ575604A (https=) |
| RU (1) | RU2446160C2 (https=) |
| TW (1) | TWI406852B (https=) |
| UY (1) | UY30586A1 (https=) |
| WO (1) | WO2008031508A1 (https=) |
| ZA (1) | ZA200900806B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101209976B (zh) * | 2006-12-29 | 2012-01-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 取代的酒石酸衍生物及其用于制备β-分泌酶抑制剂的用途 |
| WO2010065717A1 (en) | 2008-12-05 | 2010-06-10 | Mochida Pharmaceutical Co., Ltd. | Morpholinone compounds as factor ixa inhibitors |
| US8987242B2 (en) | 2008-12-05 | 2015-03-24 | Merck Sharp & Dohme Corp. | Morpholinone compounds as factor IXA inhibitors |
| ES2674745T3 (es) * | 2010-02-11 | 2018-07-03 | Bristol-Myers Squibb Company | Macrociclos como inhibidores del factor XIa |
| WO2015160636A1 (en) | 2014-04-16 | 2015-10-22 | Merck Sharp & Dohme Corp. | Factor ixa inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3731542A1 (de) * | 1987-09-17 | 1989-03-30 | Schering Ag | Neue dicarbonsaeure-bis(3,5-dicarbamoyl-2,4,6-triiod-anilide), verfahren zu deren herstellung sowie diese enthaltende roentgenkontrastmittel |
| RU2043344C1 (ru) * | 1991-05-20 | 1995-09-10 | Курский Государственный Медицинский Институт | N-2-(1- r1-5-r2-6-r3- бензимидазолил)сукцинаминовые кислоты, проявляющие нейролептическую, антигипоксическую и антиаритмическую активность |
| CA2159649A1 (en) | 1993-03-29 | 1994-10-13 | Queen's University At Kingston | Anticoagulant compounds |
| US6642252B2 (en) | 2000-11-07 | 2003-11-04 | Bristol-Myers Squibb Company | Acid derivatives useful as serine protease inhibitors |
| DE10104598A1 (de) * | 2001-02-02 | 2002-08-08 | Boehringer Ingelheim Pharma | Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel |
| US20020151595A1 (en) | 2001-02-02 | 2002-10-17 | Ries Uwe Joerg | Carboxylic acid amides having antithrombotic activity |
| EP1594505A4 (en) | 2003-02-11 | 2008-08-13 | Bristol Myers Squibb Co | PHENYLGLYCIN DERIVATIVES USEFUL AS SERINE PROTEASE INHIBITORS |
| US7638513B2 (en) * | 2004-06-02 | 2009-12-29 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
-
2007
- 2007-08-31 CN CN2007800339733A patent/CN101516833B/zh not_active Expired - Fee Related
- 2007-08-31 BR BRPI0716778-4A2A patent/BRPI0716778A2/pt not_active IP Right Cessation
- 2007-08-31 KR KR1020097005182A patent/KR20090053813A/ko not_active Ceased
- 2007-08-31 EP EP07802030.2A patent/EP2069288B1/de active Active
- 2007-08-31 RU RU2009113616/04A patent/RU2446160C2/ru not_active IP Right Cessation
- 2007-08-31 JP JP2009527719A patent/JP5249225B2/ja not_active Expired - Fee Related
- 2007-08-31 CA CA002663543A patent/CA2663543A1/en not_active Abandoned
- 2007-08-31 AU AU2007297012A patent/AU2007297012B2/en not_active Ceased
- 2007-08-31 WO PCT/EP2007/007612 patent/WO2008031508A1/de not_active Ceased
- 2007-08-31 NZ NZ575604A patent/NZ575604A/en not_active IP Right Cessation
- 2007-08-31 MY MYPI20090508A patent/MY148254A/en unknown
- 2007-08-31 MX MX2009001990A patent/MX2009001990A/es active IP Right Grant
- 2007-09-11 AR ARP070104011A patent/AR062744A1/es not_active Application Discontinuation
- 2007-09-11 UY UY30586A patent/UY30586A1/es not_active Application Discontinuation
- 2007-09-11 TW TW096133789A patent/TWI406852B/zh not_active IP Right Cessation
- 2007-09-12 CL CL200702651A patent/CL2007002651A1/es unknown
-
2009
- 2009-02-03 ZA ZA2009/00806A patent/ZA200900806B/en unknown
- 2009-03-04 CO CO09022192A patent/CO6220943A2/es not_active Application Discontinuation
- 2009-03-06 MA MA31699A patent/MA30706B1/fr unknown
- 2009-03-09 IL IL197505A patent/IL197505A0/en unknown
- 2009-03-09 US US12/400,187 patent/US8263621B2/en not_active Expired - Fee Related
- 2009-03-16 NO NO20091106A patent/NO20091106L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010503625A5 (https=) | ||
| JP2010503624A5 (https=) | ||
| ES2986037T3 (es) | Combinación que comprende un inhibidor de MEK y un inhibidor de B-Raf | |
| ES2676180T3 (es) | Terapia de combinación que comprende un inhibidor de CDK4/6 y un inhibidor de PI3K para el uso en el tratamiento de cáncer | |
| ES2673973T3 (es) | Inhibidores de tirosina cinasa de Bruton | |
| ES2716158T3 (es) | 2'-spiro-nucleótidos para el tratamiento de hepatitis C | |
| US9765107B2 (en) | Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
| JP2015512860A5 (https=) | ||
| JP2009509989A5 (https=) | ||
| RU2013147744A (ru) | Дозированная лекарственная форма для перорального применения | |
| JP2019515908A5 (https=) | ||
| JP2008500390A5 (https=) | ||
| JP2014065696A5 (https=) | ||
| JP6100700B2 (ja) | 組合せ | |
| ES2651688T3 (es) | Métodos y composiciones para la reanimación hipotensiva | |
| JP2018506531A5 (https=) | ||
| JP2008519833A5 (https=) | ||
| RU2009113602A (ru) | Изосериновые производные для применения в качестве ингибиторов фактора свертывания крови ixa | |
| AR070441A1 (es) | Clorotiofeno - amidas como inhibidores de los factores de coagulacion xa y trombina | |
| JP2006528941A5 (https=) | ||
| WO2016095814A1 (en) | Bridged ring compounds as hepatitis c virus inhibitors and preparation thereof | |
| RU2015134148A (ru) | Галеновая форма для введения активного действующего вещества | |
| ES2543834T3 (es) | Fosfonato nucleósidos útiles como principios activos en composiciones farmacéuticas para el tratamiento de infecciones víricas y compuestos intermedios para su producción | |
| AR045683A1 (es) | Derivados de bencimidazol como inhibidores del factor xa | |
| EP4419094A1 (en) | Compositions and methods for treatment of hyperproliferative, inflammatory, and immunological diseases, and infections |